Malignant melanoma is a good tumor model to investigate the activation of RAS/RAF/MEK/ERK and the PI3K/AKT/mTOR pathways as it is frequently affected by B-RAFV600E mutation that causes the activation of MAPK pathway [2]. This evidence concerns the gene AKT1 and melanoma.